[go: up one dir, main page]

GB0426393D0 - Materials and methods relating to modulators of spindle checkpoint kinases - Google Patents

Materials and methods relating to modulators of spindle checkpoint kinases

Info

Publication number
GB0426393D0
GB0426393D0 GBGB0426393.5A GB0426393A GB0426393D0 GB 0426393 D0 GB0426393 D0 GB 0426393D0 GB 0426393 A GB0426393 A GB 0426393A GB 0426393 D0 GB0426393 D0 GB 0426393D0
Authority
GB
United Kingdom
Prior art keywords
modulators
materials
methods relating
spindle checkpoint
checkpoint kinases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0426393.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Priority to GBGB0426393.5A priority Critical patent/GB0426393D0/en
Publication of GB0426393D0 publication Critical patent/GB0426393D0/en
Priority to PCT/GB2005/004622 priority patent/WO2006059121A2/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB0426393.5A 2004-12-01 2004-12-01 Materials and methods relating to modulators of spindle checkpoint kinases Ceased GB0426393D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0426393.5A GB0426393D0 (en) 2004-12-01 2004-12-01 Materials and methods relating to modulators of spindle checkpoint kinases
PCT/GB2005/004622 WO2006059121A2 (en) 2004-12-01 2005-12-01 Modulators of spindle checkpoint kinases and a taxol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0426393.5A GB0426393D0 (en) 2004-12-01 2004-12-01 Materials and methods relating to modulators of spindle checkpoint kinases

Publications (1)

Publication Number Publication Date
GB0426393D0 true GB0426393D0 (en) 2005-01-05

Family

ID=34043885

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0426393.5A Ceased GB0426393D0 (en) 2004-12-01 2004-12-01 Materials and methods relating to modulators of spindle checkpoint kinases

Country Status (2)

Country Link
GB (1) GB0426393D0 (en)
WO (1) WO2006059121A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2589918A1 (en) * 2004-12-08 2006-06-15 Dorre Grueneberg Method for measuring resistance or sensitivity to docetaxel comprising detection of tacc3
WO2008116161A2 (en) * 2007-03-22 2008-09-25 The General Hospital Corporation Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states
TW201102081A (en) 2009-05-11 2011-01-16 Oncotherapy Science Inc TTK peptides and vaccines including the same
CN116870167B (en) * 2023-08-24 2024-11-08 四川大学 A combined drug and drug composition for treating solid tumors

Also Published As

Publication number Publication date
WO2006059121A3 (en) 2007-04-05
WO2006059121A2 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
IL191139A0 (en) Novel pyridopyrazines and their use as modulators of kinases
IL181524A0 (en) Heterocyclic compounds and methods of use
IL180775A0 (en) Modulators of alph7 nicotinic acetylcholine receptors and therapeutic uses thereof
SI1984353T1 (en) Aurora kinase modulators and method of use
IL176958A0 (en) Compounds and methods of use
IL192812A0 (en) Aurora kinase modulators and method of use
IL185914A0 (en) Pyrimidine compounds and methods of use
ZA200900058B (en) Superabrasive materials and methods of manufacture
IL178593A (en) Fcγriib-specific antibodies and methods of use thereof
EP1751124A4 (en) Raf modulators and methods of use
IL213843A0 (en) 4-aminotetracyclines and methods of use thereof
ZA200805741B (en) Anti-MN antibodies and methods of using same
IL186970A0 (en) Thiazole compounds and methods of use
AU2006330807A8 (en) Antagonists of HMBG1 and/or rage and methods of use thereof
EP1874759A4 (en) C-met modulators and methods of use
EP1678168A4 (en) P70s6 kinase modulators and method of use
PL2099796T3 (en) Aza-indolyl compounds and methods of use
SI1906965T1 (en) Azaindazole compounds and methods of use
EP2021555A4 (en) Structural element and methods of use thereof
IL178161A0 (en) Bonded thin-film structures for optical modulators and methods of manufacture
ZA200707083B (en) Isoquinoline compounds and methods of use thereof
ZA200607582B (en) Anti-parasitic compounds and methods of their use
EP1871761A4 (en) Spirocyclic heterocyclic derivatives and methods of their use
GB0702729D0 (en) Methods of extending the shelf life of and revitalizing lightweight beads for use in cement compositions
GB2440843B (en) Liquid sealant and methods of use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)